NAA10 anticorps (AA 161-235)
Aperçu rapide pour NAA10 anticorps (AA 161-235) (ABIN6144318)
Antigène
Voir toutes NAA10 (ARD1A) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 161-235
-
Séquence
- HLELKEKGRH VVLGAIENKV ESKGNSPPSS GEACREEKGL AAEDSGGDSK DLSEVSETTE STDVKDSSEA SDSAS
-
Réactivité croisée
- Humain, Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 161-235 of human NAA10 (NP_003482.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NAA10 (ARD1A) (ARD1 Homolog, N-Acetyltransferase (ARD1A))
-
Autre désignation
- NAA10
-
Sujet
- N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants.,NAA10,ARD1,ARD1A,ARD1P,DXS707,MCOPS1,NATD,OGDNS,TE2,Epigenetics & Nuclear Signaling,Signal Transduction,Endocrine & Metabolism,Amino acid metabolism,NAA10
-
Poids moléculaire
- 24 kDa/26 kDa
-
ID gène
- 8260
-
UniProt
- P41227
Antigène
-